Free Trial

Nucor (NUE) Financials

Nucor logo
$252.04 -8.71 (-3.34%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$251.53 -0.51 (-0.20%)
As of 11/13/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Nucor

Annual Income Statements for Nucor

This table shows Nucor's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
81 796 1,319 2,361 1,271 721 6,827 7,607 4,525 2,027 1,744
Consolidated Net Income / (Loss)
193 900 1,381 2,481 1,371 836 7,122 8,079 4,913 2,319 2,038
Net Income / (Loss) Continuing Operations
193 900 1,381 2,481 1,371 836 7,122 8,079 4,913 2,319 2,038
Total Pre-Tax Income
242 1,299 1,750 3,229 1,783 836 9,201 10,245 6,273 2,902 2,568
Total Operating Income
410 1,429 1,882 3,325 1,901 999 9,257 10,404 6,230 2,842 2,592
Total Gross Profit
1,114 2,026 2,569 4,295 2,679 2,228 11,025 12,503 7,815 4,102 3,878
Total Revenue
16,439 16,208 20,252 25,067 22,589 20,140 36,484 41,512 34,714 30,734 32,494
Operating Revenue
16,439 16,208 20,252 25,067 22,589 20,140 36,484 41,512 34,714 30,734 32,494
Total Cost of Revenue
15,325 14,182 17,683 20,772 19,910 17,912 25,459 29,009 26,899 26,632 28,616
Operating Cost of Revenue
15,325 14,182 17,683 20,772 19,910 17,912 25,459 29,009 26,899 26,632 28,616
Total Operating Expenses
704 597 688 971 778 1,229 1,769 2,099 1,585 1,260 1,286
Selling, General & Admin Expense
459 597 688 861 711 615 1,707 1,997 1,585 1,123 1,219
Impairment Charge
245 0.00 - 110 67 614 62 102 0.00 137 67
Total Other Income / (Expense), net
-168 -130 -132 -95 -118 -164 -56 -159 43 60 -24
Interest Expense
174 169 174 136 121 153 159 170 -30 -30 59
Interest & Investment Income
5.33 39 42 40 3.31 -11 103 11 13 30 35
Income Tax Expense
49 398 369 748 412 -0.49 2,078 2,166 1,360 583 530
Net Income / (Loss) Attributable to Noncontrolling Interest
112 104 62 120 100 115 295 472 388 292 294
Basic Earnings per Share
$0.25 $2.48 $4.11 $7.44 $4.14 $2.37 $23.23 $28.88 $18.05 $8.47 $7.53
Weighted Average Basic Shares Outstanding
-93.90M 319.56M 319.99M 315.86M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Diluted Earnings per Share
$0.25 $2.48 $4.10 $7.42 $4.14 $2.36 $23.16 $28.79 $18.00 $8.46 $7.52
Weighted Average Diluted Shares Outstanding
-93.90M 319.56M 319.99M 315.86M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Weighted Average Basic & Diluted Shares Outstanding
-93.90M 319.56M 319.99M 315.86M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Cash Dividends to Common per Share
$1.49 $1.50 $1.51 $3.08 $1.60 $1.61 $1.72 $2.01 $2.07 $2.17 $2.21

Quarterly Income Statements for Nucor

This table shows Nucor's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/30/2024 6/29/2024 9/28/2024 12/31/2024 4/5/2025 7/5/2025 10/4/2025 12/31/2025 4/4/2026 7/4/2026 10/3/2026
Net Income / (Loss) Attributable to Common Shareholders
845 645 250 287 156 603 607 378 743 1,156 1,319
Consolidated Net Income / (Loss)
959 712 303 345 226 706 683 423 870 1,280 1,473
Net Income / (Loss) Continuing Operations
959 712 303 345 226 706 683 423 870 1,280 1,473
Total Pre-Tax Income
1,225 898 389 390 285 899 883 501 1,096 1,625 1,867
Total Operating Income
1,178 886 391 387 295 908 888 501 1,108 1,629 1,865
Total Gross Profit
1,523 1,194 758 627 605 1,223 1,188 862 1,501 2,034 2,326
Total Revenue
8,137 8,077 7,444 7,076 7,830 8,456 8,521 7,687 9,496 10,397 11,249
Operating Revenue
8,137 8,077 7,444 7,076 7,830 8,456 8,521 7,687 9,496 10,397 11,249
Total Cost of Revenue
6,614 6,883 6,686 6,449 7,225 7,233 7,333 6,825 7,995 8,363 8,923
Operating Cost of Revenue
6,614 6,883 6,686 6,449 7,225 7,233 7,333 6,825 7,995 8,363 8,923
Total Operating Expenses
345 308 367 240 310 315 300 361 393 405 461
Selling, General & Admin Expense
345 294 244 226 281 304 300 334 378 405 444
Impairment Charge
0.00 14 123 - 29 11 0.00 27 15 0.00 17
Total Other Income / (Expense), net
47 12 -2.00 3.11 -10 -9.00 -5.00 - -12 -4.00 2.00
Interest Expense
-38 -2.00 7.00 2.81 14 19 15 11 19 12 7.00
Interest & Investment Income
9.00 10 5.00 5.92 4.00 10 10 11 7.00 8.00 9.00
Income Tax Expense
266 186 86 45 59 193 200 78 226 345 394
Net Income / (Loss) Attributable to Noncontrolling Interest
114 67 53 58 70 103 76 45 127 124 154
Basic Earnings per Share
$3.46 $2.68 $1.05 $1.28 $0.67 $2.60 $2.63 $1.63 $3.23 $5.05 $5.81
Weighted Average Basic Shares Outstanding
243.10M 239.60M 236.50M 230.54M 232.70M 230.60M 229.90M 227.77M 228.90M 228.20M 226.40M
Diluted Earnings per Share
$3.46 $2.68 $1.05 $1.27 $0.67 $2.60 $2.63 $1.62 $3.23 $5.04 $5.80
Weighted Average Diluted Shares Outstanding
243.50M 240M 236.80M 230.54M 232.90M 230.80M 230.20M 227.77M 229.30M 228.50M 226.70M
Weighted Average Basic & Diluted Shares Outstanding
239.76M 237.34M 234.81M 230.54M 230.75M 229.54M 228.86M 227.77M 227.74M 226.88M 224.94M

Annual Cash Flow Statements for Nucor

This table details how cash moves in and out of Nucor's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
663 106 -1,106 450 136 1,220 -246 1,852 2,026 -2,829 -1,298
Net Cash From Operating Activities
1,909 1,750 1,055 2,394 2,809 2,697 6,231 10,072 7,112 3,979 3,234
Net Cash From Continuing Operating Activities
1,909 1,750 1,055 2,394 2,809 2,697 6,231 10,072 7,112 3,979 3,234
Net Income / (Loss) Continuing Operations
193 900 1,381 2,481 1,371 836 7,122 8,079 4,913 2,319 2,038
Consolidated Net Income / (Loss)
193 900 1,381 2,481 1,371 836 7,122 8,079 4,913 2,319 2,038
Depreciation Expense
626 613 636 631 649 702 735 827 931 1,094 1,226
Amortization Expense
74 74 91 89 86 83 129 235 238 262 254
Non-Cash Adjustments To Reconcile Net Income
40 58 72 173 191 709 95 285 151 264 191
Changes in Operating Assets and Liabilities, net
975 104 -1,124 -980 512 367 -1,851 646 879 40 -475
Net Cash From Investing Activities
-442 -1,025 -919 -1,030 -1,794 -1,764 -2,874 -5,703 -2,496 -3,734 -3,226
Net Cash From Continuing Investing Activities
-442 -1,025 -919 -1,030 -1,794 -1,764 -2,874 -5,703 -2,496 -3,734 -3,226
Purchase of Property, Plant & Equipment
-374 -605 -449 -983 -1,477 -1,543 -1,622 -1,948 -2,214 -3,173 -3,422
Acquisitions
-19 -475 -544 -33 -83 -88 -1,426 -3,553 -71 -758 -2.00
Purchase of Investments
-192 -713 -109 -121 -414 -533 -494 -914 -1,507 -1,296 -986
Sale of Property, Plant & Equipment
29 19 25 32 42 41 19 32 15 17 45
Divestitures
- 135 - 0.00 68 0.00 0.00 100 0.00 1.00 0.00
Sale and/or Maturity of Investments
111 600 150 50 68 392 649 590 1,317 1,487 1,140
Other Investing Activities, net
3.01 14 7.39 25 2.87 -33 0.40 -10 -36 -12 -1.00
Net Cash From Financing Activities
-804 -626 -1,242 -908 -880 286 -3,603 -2,511 -2,593 -3,058 -1,315
Net Cash From Continuing Financing Activities
-804 -626 -1,242 -908 -880 286 -3,603 -2,511 -2,593 -3,058 -1,315
Repayment of Debt
-18 -13 -603 -508 -9.13 -287 38 -1,195 -52 82 -1,112
Repurchase of Common Equity
-67 -5.17 -90 -862 -299 -46 -3,276 -2,776 -1,554 -2,217 -709
Payment of Dividends
-551 -581 -576 -542 -568 -607 -634 -866 -950 -874 -761
Issuance of Debt
-156 -33 35 1,001 4.57 1,233 197 2,092 0.00 0.00 1,217
Other Financing Activities, net
-12 -9.60 -14 -22 -8.90 -7.26 72 234 -37 -49 50
Effect of Exchange Rate Changes
- - - - - - -0.32 -6.00 3.00 -16 9.00

Quarterly Cash Flow Statements for Nucor

This table details how cash moves in and out of Nucor's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/30/2024 6/29/2024 9/28/2024 12/31/2024 4/5/2025 7/5/2025 10/4/2025 12/31/2025 4/4/2026 7/4/2026 10/3/2026
Net Change in Cash & Equivalents
-1,829 81 -376 -705 -402 -1,210 275 39 -34 252 989
Net Cash From Operating Activities
460 1,485 1,301 733 364 732 1,339 799 886 1,400 2,236
Net Cash From Continuing Operating Activities
460 1,477 1,309 733 364 732 1,339 799 886 1,400 2,236
Net Income / (Loss) Continuing Operations
959 712 303 345 226 706 683 423 870 1,280 1,473
Consolidated Net Income / (Loss)
959 712 303 345 226 706 683 423 870 1,280 1,473
Depreciation Expense
257 271 281 285 303 303 304 316 321 320 326
Amortization Expense
59 61 69 73 65 63 63 63 63 63 62
Non-Cash Adjustments To Reconcile Net Income
19 45 171 29 40 50 14 87 44 54 46
Changes in Operating Assets and Liabilities, net
-834 388 484 1.58 -270 -390 275 -90 -412 -317 329
Net Cash From Investing Activities
-890 -711 -1,170 -964 -1,180 -543 -786 -717 -446 -510 -579
Net Cash From Continuing Investing Activities
-890 -703 -1,178 -964 -1,180 -543 -786 -717 -446 -510 -579
Purchase of Property, Plant & Equipment
-670 -801 -823 -879 -859 -954 -807 -802 -661 -571 -629
Purchase of Investments
-647 -240 -150 -259 -452 -215 -206 -113 -143 -16 -8.00
Sale of Property, Plant & Equipment
4.00 5.09 2.30 5.17 3.00 36 3.00 3.00 14 7.00 13
Divestitures
0.00 - - -0.44 0.00 - - - 0.00 3.00 1.00
Sale and/or Maturity of Investments
422 434 354 277 127 590 221 202 326 56 50
Other Investing Activities, net
0.00 9.20 0.41 -22 2.00 - 2.00 -5.00 18 11 -6.00
Net Cash From Financing Activities
-1,396 -692 -510 -461 414 -1,410 -273 -46 -472 -632 -669
Net Cash From Continuing Financing Activities
-1,396 -692 -510 -461 414 -1,410 -273 -46 -472 -632 -669
Repayment of Debt
-7.00 -17 -3.65 98 -48 -942 -97 -25 1.00 -42 -7.00
Repurchase of Common Equity
-1,001 -500 -400 -315 -309 -200 -100 -100 -125 -350 -502
Payment of Dividends
-399 -181 -148 -147 -301 -171 -144 -145 -349 -191 -160
Effect of Exchange Rate Changes
- - - - 0.00 - - 3.00 - - 1.00

Annual Balance Sheets for Nucor

This table presents Nucor's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
14,327 15,224 15,841 17,921 18,345 20,125 25,823 32,479 35,340 33,940 35,104
Total Current Assets
5,854 6,506 6,824 8,636 8,226 9,489 12,800 14,692 16,386 12,475 11,765
Cash & Equivalents
1,939 2,046 949 1,399 1,535 2,640 2,365 4,281 6,383 3,558 2,260
Short-Term Investments
100 150 50 0.00 300 408 253 577 747 581 439
Accounts Receivable
1,384 1,632 2,029 2,506 2,160 2,299 3,854 3,591 2,953 2,675 3,105
Inventories, net
2,245 2,480 3,462 4,554 3,842 3,569 6,011 5,454 5,578 5,106 5,462
Other Current Assets
186 199 335 178 390 573 317 789 725 555 499
Plant, Property, & Equipment, net
4,891 5,079 5,093 5,335 6,179 6,899 8,115 9,617 11,050 13,243 15,306
Total Noncurrent Assets
3,581 3,638 3,924 3,950 3,940 3,738 4,909 8,090 7,900 8,222 8,033
Goodwill
2,011 2,053 2,196 2,184 2,201 2,230 2,827 3,920 3,969 4,288 4,297
Intangible Assets
771 867 915 829 742 668 1,104 3,322 3,108 3,134 2,880
Other Noncurrent Operating Assets
799 719 813 937 996 840 978 848 823 800 856
Total Liabilities & Shareholders' Equity
14,327 15,224 15,841 17,921 18,345 20,125 25,823 32,479 35,340 33,940 35,104
Total Liabilities
6,477 6,969 6,756 7,719 7,553 8,894 11,219 12,909 13,217 12,523 12,980
Total Current Liabilities
1,385 2,390 2,825 2,806 2,464 2,628 5,157 4,330 4,595 4,977 4,004
Short-Term Debt
51 618 553 58 92 69 723 78 193 1,267 212
Accounts Payable
567 838 1,181 1,428 1,202 1,432 1,974 1,650 2,020 1,832 1,890
Accrued Expenses
478 505 574 611 660 664 965 948 1,056 975 1,020
Current Employee Benefit Liabilities
289 429 517 709 511 463 1,495 1,654 1,326 903 882
Total Noncurrent Liabilities
5,092 4,579 3,932 4,912 5,090 6,266 6,062 8,580 8,622 7,546 8,976
Long-Term Debt
4,337 3,739 3,242 4,233 4,291 5,272 4,961 6,614 6,649 5,683 6,909
Noncurrent Deferred & Payable Income Tax Liabilities
755 840 689 679 798 994 1,100 1,966 1,973 1,863 2,067
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
7,850 8,255 9,085 10,202 10,791 11,232 14,604 19,570 22,123 21,417 22,124
Total Preferred & Common Equity
7,478 7,880 8,739 9,792 10,358 10,789 14,016 18,415 20,940 20,294 20,936
Total Common Equity
7,478 7,880 8,739 9,792 10,358 10,789 14,016 18,415 20,940 20,294 20,936
Common Stock
2,070 2,126 2,173 2,226 2,260 2,273 2,293 2,296 2,328 2,375 2,405
Retained Earnings
7,317 7,631 8,464 10,337 11,115 11,344 17,674 24,755 28,762 30,271 31,504
Treasury Stock
-1,558 -1,560 -1,643 -2,467 -2,714 -2,710 -5,835 -8,498 -9,988 -12,144 -12,779
Accumulated Other Comprehensive Income / (Loss)
-351 -318 -255 -304 -303 -119 -115 -138 -162 -208 -194
Noncontrolling Interest
372 375 346 410 433 443 587 1,155 1,183 1,123 1,188

Quarterly Balance Sheets for Nucor

This table presents Nucor's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 4/5/2025 7/5/2025 10/4/2025 4/4/2026 7/4/2026 10/3/2026
Total Assets
35,340 33,933 34,185 34,346 33,940 34,699 34,217 34,776 35,635 36,954 38,364
Total Current Assets
16,386 14,643 14,258 13,521 12,475 12,760 11,719 11,808 12,088 13,156 14,354
Cash & Equivalents
6,383 4,558 4,639 4,263 3,558 3,156 1,946 2,221 2,226 2,478 3,467
Short-Term Investments
747 981 795 596 581 905 537 524 255 214 173
Accounts Receivable
2,953 3,157 3,113 2,949 2,675 2,965 3,388 3,288 3,567 4,045 4,296
Inventories, net
5,578 5,590 5,256 5,126 5,106 5,256 5,462 5,393 5,644 6,020 6,020
Other Current Assets
725 357 455 587 555 478 386 382 396 399 398
Plant, Property, & Equipment, net
11,050 11,457 11,999 12,580 13,243 13,759 14,303 14,821 15,596 15,863 16,103
Total Noncurrent Assets
7,900 7,833 7,928 8,245 8,222 8,180 8,195 8,147 7,951 7,935 7,907
Goodwill
3,969 3,956 4,000 4,274 4,288 4,287 4,299 4,294 4,295 4,289 4,290
Intangible Assets
3,108 3,049 3,051 3,194 3,134 3,069 3,006 2,943 2,817 2,754 2,693
Other Noncurrent Operating Assets
823 828 876 777 800 824 890 910 839 892 924
Total Liabilities & Shareholders' Equity
35,340 33,933 34,185 34,346 33,940 34,699 34,217 34,776 35,635 36,954 38,364
Total Liabilities
13,217 12,207 12,413 12,790 12,523 13,584 12,725 12,845 13,087 13,688 14,273
Total Current Liabilities
4,595 3,646 4,865 5,217 4,977 5,059 4,146 4,257 4,167 5,246 5,830
Short-Term Debt
193 204 1,244 1,254 1,267 1,191 189 167 247 710 709
Accounts Payable
2,020 1,616 1,745 1,903 1,832 2,272 2,183 2,145 2,109 2,357 2,380
Accrued Expenses
1,056 1,140 1,019 1,085 975 1,022 1,029 1,046 1,110 1,177 1,406
Current Employee Benefit Liabilities
1,326 686 857 975 903 574 745 899 701 1,002 1,335
Total Noncurrent Liabilities
8,622 8,561 7,547 7,573 7,546 8,525 8,579 8,588 8,920 8,442 8,443
Long-Term Debt
6,649 6,648 5,649 5,685 5,683 6,689 6,692 6,686 6,877 6,389 6,384
Noncurrent Deferred & Payable Income Tax Liabilities
1,973 1,913 1,899 1,888 1,863 1,836 1,887 1,902 2,043 2,053 2,059
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
22,123 21,726 21,773 21,557 21,417 21,115 21,492 21,931 22,548 23,266 24,091
Total Preferred & Common Equity
20,940 20,694 20,724 20,473 20,294 20,069 20,389 20,770 21,453 22,109 22,811
Total Common Equity
20,940 20,694 20,724 20,473 20,294 20,069 20,389 20,770 21,453 22,109 22,811
Common Stock
2,328 2,363 2,341 2,360 2,375 2,397 2,365 2,385 2,426 2,359 2,373
Retained Earnings
28,762 29,476 29,992 30,114 30,271 30,300 30,775 31,255 32,118 33,146 34,338
Accumulated Other Comprehensive Income / (Loss)
-162 -177 -178 -168 -208 -198 -167 -189 -206 -214 -222
Other Equity Adjustments
- -10,968 -11,432 -11,833 - -12,430 -12,584 -12,681 -12,885 -13,182 -13,678
Noncontrolling Interest
1,183 1,032 1,049 1,084 1,123 1,046 1,103 1,161 1,095 1,157 1,280

Annual Metrics And Ratios for Nucor

This table displays calculated financial ratios and metrics derived from Nucor's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-22.11% -1.41% 24.95% 23.77% -9.89% -10.84% 81.15% 13.78% -16.38% -11.47% 5.73%
EBITDA Growth
-45.25% 90.63% 23.28% 55.02% -34.83% -32.28% 467.10% 13.29% -35.47% -43.26% -3.00%
EBIT Growth
-68.53% 248.51% 31.68% 76.67% -42.82% -47.43% 826.34% 12.39% -40.12% -54.38% -8.80%
NOPAT Growth
-62.99% 202.77% 49.83% 72.05% -42.77% -31.60% 616.66% 14.50% -40.53% -53.46% -9.42%
Net Income Growth
-75.21% 366.46% 53.33% 79.71% -44.75% -39.02% 751.93% 13.43% -39.19% -52.80% -12.12%
EPS Growth
-88.15% 892.00% 65.32% 80.98% -44.20% -43.00% 881.36% 24.31% -37.48% -53.00% -11.11%
Operating Cash Flow Growth
51.04% -8.32% -39.70% 126.84% 17.35% -4.01% 131.04% 61.65% -29.39% -44.05% -18.72%
Free Cash Flow Firm Growth
958.99% -53.49% -97.45% 6,695.14% -9.28% -33.03% 270.67% 50.75% -3.97% -102.88% -107.19%
Invested Capital Growth
-11.59% 2.13% 14.06% 10.21% 1.87% 1.39% 30.65% 20.67% 2.38% 10.98% 9.57%
Revenue Q/Q Growth
-8.60% 3.18% 5.94% 5.04% -4.90% 0.64% 16.27% -3.80% -2.85% -2.01% 1.92%
EBITDA Q/Q Growth
-40.28% 49.11% 2.96% 15.58% -20.59% 2.83% 38.32% -10.82% -6.44% -12.60% 3.43%
EBIT Q/Q Growth
-64.35% 95.52% 3.58% 19.84% -26.83% 4.63% 42.48% -12.14% -7.90% -18.65% 4.60%
NOPAT Q/Q Growth
-61.09% 98.55% 18.48% 12.18% -27.18% 53.06% 35.76% -10.71% -9.56% -18.02% 4.06%
Net Income Q/Q Growth
-73.16% 121.29% 18.95% 13.03% -28.51% 53.56% 36.76% -11.16% -8.45% -18.54% 3.98%
EPS Q/Q Growth
-86.49% 169.57% 20.59% 13.11% -29.23% 67.38% 38.52% -8.83% -9.00% -18.34% 4.88%
Operating Cash Flow Q/Q Growth
-9.72% 33.66% -23.13% 9.30% 7.53% -6.84% 51.54% -0.76% -12.47% -16.51% 2.08%
Free Cash Flow Firm Q/Q Growth
17.86% -10.24% 107.75% -1.48% -2.37% -16.70% 374.79% -0.36% -29.07% -121.28% 38.61%
Invested Capital Q/Q Growth
-2.56% 3.09% 2.32% 4.52% 0.38% 4.32% 0.36% -4.06% 1.74% 2.50% 1.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
6.78% 12.50% 12.69% 17.14% 11.86% 11.06% 30.22% 30.12% 22.51% 13.35% 11.93%
EBITDA Margin
6.75% 13.06% 12.88% 16.13% 11.67% 8.86% 27.74% 27.62% 21.31% 13.66% 12.53%
Operating Margin
2.49% 8.82% 9.29% 13.26% 8.42% 4.96% 25.37% 25.06% 17.95% 9.25% 7.98%
EBIT Margin
2.49% 8.82% 9.29% 13.26% 8.42% 4.96% 25.37% 25.06% 17.95% 9.25% 7.98%
Profit (Net Income) Margin
1.17% 5.56% 6.82% 9.90% 6.07% 4.15% 19.52% 19.46% 14.15% 7.55% 6.27%
Tax Burden Percent
79.81% 69.33% 78.89% 76.83% 76.90% 100.06% 77.41% 78.86% 78.32% 79.91% 79.36%
Interest Burden Percent
58.98% 90.87% 92.99% 97.13% 93.79% 83.61% 99.40% 98.47% 100.69% 102.11% 99.07%
Effective Tax Rate
20.19% 30.67% 21.11% 23.17% 23.10% -0.06% 22.59% 21.14% 21.68% 20.09% 20.64%
Return on Invested Capital (ROIC)
3.01% 9.61% 13.32% 20.45% 11.06% 7.44% 45.94% 42.08% 22.61% 9.86% 8.10%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.61% 5.60% 9.12% 17.88% 7.72% 0.68% 44.33% 36.88% 27.22% 13.67% 7.58%
Return on Net Nonoperating Assets (RNNOA)
-0.59% 1.57% 2.61% 5.27% 2.00% 0.15% 9.20% 5.20% 0.95% 0.79% 1.26%
Return on Equity (ROE)
2.42% 11.18% 15.92% 25.73% 13.06% 7.59% 55.14% 47.28% 23.57% 10.65% 9.36%
Cash Return on Invested Capital (CROIC)
15.31% 7.51% 0.18% 10.74% 9.20% 6.06% 19.36% 23.35% 20.26% -0.55% -1.03%
Operating Return on Assets (OROA)
2.74% 9.67% 12.12% 19.69% 10.48% 5.20% 40.29% 35.69% 18.37% 8.20% 7.51%
Return on Assets (ROA)
1.29% 6.09% 8.89% 14.70% 7.56% 4.35% 31.00% 27.71% 14.49% 6.69% 5.90%
Return on Common Equity (ROCE)
2.32% 10.66% 15.26% 24.72% 12.54% 7.29% 52.94% 44.87% 22.25% 10.09% 8.86%
Return on Equity Simple (ROE_SIMPLE)
2.58% 11.43% 15.80% 25.34% 13.24% 7.75% 50.81% 43.87% 23.46% 11.43% 0.00%
Net Operating Profit after Tax (NOPAT)
327 991 1,485 2,554 1,462 1,000 7,166 8,204 4,879 2,271 2,057
NOPAT Margin
1.99% 6.11% 7.33% 10.19% 6.47% 4.96% 19.64% 19.76% 14.06% 7.39% 6.33%
Net Nonoperating Expense Percent (NNEP)
4.62% 4.01% 4.20% 2.57% 3.34% 6.77% 1.61% 5.20% -4.61% -3.81% 0.53%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 31.24% 16.85% 8.01% 7.03%
Cost of Revenue to Revenue
93.22% 87.50% 87.31% 82.86% 88.14% 88.94% 69.78% 69.88% 77.49% 86.65% 88.07%
SG&A Expenses to Revenue
2.79% 3.68% 3.39% 3.43% 3.15% 3.05% 4.68% 4.81% 4.57% 3.65% 3.75%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
4.28% 3.68% 3.39% 3.87% 3.44% 6.10% 4.85% 5.06% 4.57% 4.10% 3.96%
Earnings before Interest and Taxes (EBIT)
410 1,429 1,882 3,325 1,901 999 9,257 10,404 6,230 2,842 2,592
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,110 2,116 2,609 4,044 2,636 1,785 10,121 11,466 7,399 4,198 4,072
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.41 2.03 2.00 1.48 1.51 1.42 2.25 1.79 2.01 1.35 1.78
Price to Tangible Book Value (P/TBV)
2.25 3.23 3.11 2.13 2.11 1.94 3.13 2.94 3.04 2.13 2.71
Price to Revenue (P/Rev)
0.64 0.99 0.86 0.58 0.69 0.76 0.87 0.79 1.21 0.89 1.15
Price to Earnings (P/E)
130.72 20.10 13.28 6.12 12.29 21.18 4.63 4.32 9.32 13.52 21.40
Dividend Yield
4.52% 2.99% 2.75% 3.34% 3.11% 3.19% 1.55% 1.57% 1.21% 1.86% 1.35%
Earnings Yield
0.77% 4.98% 7.53% 16.33% 8.14% 4.72% 21.61% 23.12% 10.73% 7.40% 4.67%
Enterprise Value to Invested Capital (EV/IC)
1.30 1.78 1.74 1.36 1.39 1.33 1.99 1.68 1.97 1.29 1.62
Enterprise Value to Revenue (EV/Rev)
0.81 1.14 1.02 0.71 0.82 0.89 0.97 0.86 1.24 1.02 1.32
Enterprise Value to EBITDA (EV/EBITDA)
11.96 8.76 7.91 4.39 7.06 10.09 3.48 3.12 5.82 7.47 10.55
Enterprise Value to EBIT (EV/EBIT)
32.37 12.97 10.97 5.34 9.79 18.03 3.81 3.44 6.91 11.03 16.57
Enterprise Value to NOPAT (EV/NOPAT)
40.56 18.71 13.91 6.95 12.73 18.02 4.92 4.36 8.82 13.80 20.87
Enterprise Value to Operating Cash Flow (EV/OCF)
6.95 10.59 19.57 7.42 6.62 6.68 5.66 3.55 6.05 7.88 13.28
Enterprise Value to Free Cash Flow (EV/FCFF)
7.98 23.95 1,046.45 13.25 15.29 22.11 11.67 7.87 9.85 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.56 0.53 0.42 0.42 0.41 0.48 0.39 0.34 0.31 0.32 0.32
Long-Term Debt to Equity
0.55 0.45 0.36 0.41 0.40 0.47 0.34 0.34 0.30 0.27 0.31
Financial Leverage
0.36 0.28 0.29 0.29 0.26 0.22 0.21 0.14 0.04 0.06 0.17
Leverage Ratio
1.88 1.83 1.79 1.75 1.73 1.75 1.78 1.71 1.63 1.59 1.59
Compound Leverage Factor
1.11 1.67 1.67 1.70 1.62 1.46 1.77 1.68 1.64 1.62 1.57
Debt to Total Capital
35.86% 34.55% 29.47% 29.61% 28.88% 32.23% 28.02% 25.48% 23.62% 24.50% 24.35%
Short-Term Debt to Total Capital
0.42% 4.90% 4.29% 0.40% 0.60% 0.42% 3.57% 0.30% 0.67% 4.47% 0.72%
Long-Term Debt to Total Capital
35.44% 29.65% 25.17% 29.21% 28.28% 31.81% 24.45% 25.18% 22.96% 20.03% 23.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.04% 2.97% 2.68% 2.83% 2.86% 2.67% 2.90% 4.40% 4.08% 3.96% 4.06%
Common Equity to Total Capital
61.10% 62.48% 67.85% 67.56% 68.26% 65.10% 69.09% 70.12% 72.29% 71.54% 71.59%
Debt to EBITDA
3.95 2.06 1.45 1.06 1.66 2.99 0.56 0.58 0.92 1.66 1.75
Net Debt to EBITDA
2.12 1.02 1.07 0.72 0.97 1.28 0.30 0.15 -0.04 0.67 1.09
Long-Term Debt to EBITDA
3.91 1.77 1.24 1.05 1.63 2.95 0.49 0.58 0.90 1.35 1.70
Debt to NOPAT
13.41 4.40 2.56 1.68 3.00 5.34 0.79 0.82 1.40 3.06 3.46
Net Debt to NOPAT
7.18 2.18 1.88 1.13 1.74 2.29 0.43 0.21 -0.06 1.24 2.15
Long-Term Debt to NOPAT
13.25 3.77 2.18 1.66 2.94 5.27 0.69 0.81 1.36 2.50 3.36
Altman Z-Score
3.31 3.78 4.28 4.33 4.04 3.39 5.60 5.31 5.02 4.01 4.42
Noncontrolling Interest Sharing Ratio
4.24% 4.64% 4.16% 3.92% 4.02% 3.98% 3.99% 5.10% 5.61% 5.30% 5.31%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.23 2.72 2.42 3.08 3.34 3.61 2.48 3.39 3.57 2.51 2.94
Quick Ratio
2.47 1.60 1.07 1.39 1.62 2.03 1.25 1.95 2.19 1.37 1.45
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,664 774 20 1,341 1,216 815 3,020 4,552 4,371 -126 -261
Operating Cash Flow to CapEx
553.70% 298.50% 249.35% 251.75% 195.69% 179.52% 388.79% 525.68% 323.42% 126.08% 95.77%
Free Cash Flow to Firm to Interest Expense
9.59 4.57 0.11 9.89 10.02 5.32 19.01 26.78 0.00 0.00 -4.42
Operating Cash Flow to Interest Expense
11.00 10.34 6.08 17.66 23.14 17.60 39.22 59.25 0.00 0.00 54.81
Operating Cash Flow Less CapEx to Interest Expense
9.01 6.88 3.64 10.65 11.31 7.80 29.13 47.98 0.00 0.00 -2.42
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.10 1.10 1.30 1.48 1.25 1.05 1.59 1.42 1.02 0.89 0.94
Accounts Receivable Turnover
9.52 10.75 11.07 11.06 9.68 9.03 11.86 11.15 10.61 10.92 11.24
Inventory Turnover
6.14 6.00 5.95 5.18 4.74 4.83 5.31 5.06 4.88 4.99 5.42
Fixed Asset Turnover
3.23 3.25 3.98 4.81 3.92 3.08 4.86 4.68 3.36 2.53 2.28
Accounts Payable Turnover
19.64 20.19 17.51 15.92 15.14 13.60 14.95 16.01 14.66 13.83 15.38
Days Sales Outstanding (DSO)
38.32 33.95 32.98 33.01 37.69 40.41 30.78 32.73 34.40 33.42 32.46
Days Inventory Outstanding (DIO)
59.43 60.81 61.32 70.42 76.96 75.51 68.68 72.13 74.85 73.21 67.40
Days Payable Outstanding (DPO)
18.58 18.08 20.84 22.93 24.11 26.84 24.42 22.80 24.90 26.40 23.74
Cash Conversion Cycle (CCC)
79.17 76.69 73.46 80.50 90.55 89.08 75.04 82.06 84.35 80.24 76.12
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,199 10,416 11,881 13,094 13,340 13,525 17,671 21,323 21,831 24,228 26,546
Invested Capital Turnover
1.51 1.57 1.82 2.01 1.71 1.50 2.34 2.13 1.61 1.33 1.28
Increase / (Decrease) in Invested Capital
-1,337 217 1,465 1,213 245 185 4,146 3,652 508 2,397 2,318
Enterprise Value (EV)
13,274 18,538 20,649 17,761 18,601 18,014 35,246 35,805 43,055 31,339 42,939
Market Capitalization
10,553 16,002 17,507 14,459 15,619 15,278 31,592 32,897 42,164 27,405 37,329
Book Value per Share
$23.40 $24.74 $27.49 $31.19 $34.16 $35.73 $49.04 $71.78 $85.18 $86.43 $91.48
Tangible Book Value per Share
$14.69 $15.57 $17.70 $21.59 $24.45 $26.14 $35.29 $43.55 $56.39 $54.82 $60.12
Total Capital
12,238 12,612 12,880 14,493 15,174 16,572 20,289 26,261 28,965 28,367 29,245
Total Debt
4,388 4,357 3,795 4,291 4,383 5,341 5,685 6,691 6,842 6,950 7,121
Total Long-Term Debt
4,337 3,739 3,242 4,233 4,291 5,272 4,961 6,614 6,649 5,683 6,909
Net Debt
2,349 2,161 2,796 2,892 2,548 2,293 3,067 1,753 -292 2,811 4,422
Capital Expenditures (CapEx)
345 586 423 951 1,436 1,502 1,603 1,916 2,199 3,156 3,377
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,481 2,538 3,553 4,489 4,020 3,882 5,748 5,501 4,850 4,626 5,274
Debt-free Net Working Capital (DFNWC)
4,521 4,734 4,552 5,888 5,854 6,930 8,366 10,440 11,984 8,765 7,973
Net Working Capital (NWC)
4,469 4,116 4,000 5,830 5,763 6,861 7,642 10,362 11,791 7,498 7,761
Net Nonoperating Expense (NNE)
134 90 104 73 91 164 43 125 -34 -48 19
Net Nonoperating Obligations (NNO)
2,349 2,161 2,796 2,892 2,548 2,293 3,067 1,753 -292 2,811 4,422
Total Depreciation and Amortization (D&A)
700 687 727 720 735 785 865 1,062 1,169 1,356 1,480
Debt-free, Cash-free Net Working Capital to Revenue
15.09% 15.66% 17.55% 17.91% 17.79% 19.28% 15.75% 13.25% 13.97% 15.05% 16.23%
Debt-free Net Working Capital to Revenue
27.50% 29.21% 22.48% 23.49% 25.92% 34.41% 22.93% 25.15% 34.52% 28.52% 24.54%
Net Working Capital to Revenue
27.19% 25.40% 19.75% 23.26% 25.51% 34.07% 20.95% 24.96% 33.97% 24.40% 23.88%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.11 $2.48 $4.11 $7.44 $4.14 $2.37 $23.23 $28.88 $18.05 $8.47 $7.53
Adjusted Weighted Average Basic Shares Outstanding
317.94M 318.85M 317.94M 305.38M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Adjusted Diluted Earnings per Share
$1.11 $2.48 $4.10 $7.42 $4.14 $2.36 $23.16 $28.79 $18.00 $8.46 $7.52
Adjusted Weighted Average Diluted Shares Outstanding
317.94M 318.85M 317.94M 305.38M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
317.94M 318.85M 317.94M 305.38M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Normalized Net Operating Profit after Tax (NOPAT)
523 991 1,485 2,639 1,513 1,129 7,214 8,285 4,879 2,381 2,110
Normalized NOPAT Margin
3.18% 6.11% 7.33% 10.53% 6.70% 5.61% 19.77% 19.96% 14.06% 7.75% 6.49%
Pre Tax Income Margin
1.47% 8.01% 8.64% 12.88% 7.89% 4.15% 25.22% 24.68% 18.07% 9.44% 7.90%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.36 8.44 10.84 24.53 15.66 6.52 58.27 61.20 0.00 0.00 43.93
NOPAT to Interest Expense
1.89 5.85 8.55 18.85 12.04 6.53 45.11 48.26 0.00 0.00 34.87
EBIT Less CapEx to Interest Expense
0.38 4.98 8.40 17.51 3.83 -3.28 48.18 49.93 0.00 0.00 -13.31
NOPAT Less CapEx to Interest Expense
-0.10 2.39 6.11 11.83 0.21 -3.28 35.02 36.99 0.00 0.00 -22.37
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
285.64% 64.49% 41.74% 21.83% 41.46% 72.62% 8.90% 10.72% 19.34% 37.69% 37.34%
Augmented Payout Ratio
320.09% 65.06% 48.28% 56.56% 63.24% 78.10% 54.90% 45.08% 50.97% 133.29% 72.13%

Quarterly Metrics And Ratios for Nucor

This table displays calculated financial ratios and metrics derived from Nucor's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/30/2024 6/29/2024 9/28/2024 12/31/2024 4/5/2025 7/5/2025 10/4/2025 12/31/2025 4/4/2026 7/4/2026 10/3/2026
DEI Shares Outstanding
- - - - - - - - 227,740,950.00 226,875,676.00 224,944,177.00
DEI Adjusted Shares Outstanding
- - - - - - - - 227,740,950.00 226,875,676.00 224,944,177.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 3.26 5.10 5.86
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-6.58% -15.18% -15.17% -8.17% -3.77% 4.69% 14.47% 8.63% 21.28% 22.95% 32.02%
EBITDA Growth
-20.91% -47.80% -59.43% -44.82% -55.62% 4.60% 69.37% 18.12% 125.04% 57.93% 79.52%
EBIT Growth
-26.77% -56.70% -74.58% -62.72% -74.96% 2.48% 127.11% 29.46% 275.59% 79.41% 110.02%
NOPAT Growth
-25.70% -55.66% -74.86% -59.28% -74.63% 1.51% 125.53% 23.56% 275.98% 79.95% 114.22%
Net Income Growth
-22.14% -55.13% -75.20% -60.47% -76.43% -0.84% 125.41% 22.61% 284.96% 81.30% 115.67%
EPS Growth
-22.25% -53.87% -77.02% -59.94% -80.64% -2.99% 150.48% 27.56% 382.09% 93.85% 120.53%
Operating Cash Flow Growth
-61.92% -22.66% -47.21% -51.76% -20.87% -50.71% 2.92% 9.00% 143.41% 91.26% 66.99%
Free Cash Flow Firm Growth
93.44% -192.57% -194.72% -717.46% -1,151.48% 91.36% 8.49% 7.77% 17.12% 74.32% 98.04%
Invested Capital Growth
4.80% 0.00% 10.15% 10.98% 8.23% 11.45% 10.16% 9.57% 9.05% 6.89% 5.78%
Revenue Q/Q Growth
0.00% -0.74% -7.84% -4.95% 10.66% 7.99% 0.77% -9.79% 23.53% 9.49% 8.19%
EBITDA Q/Q Growth
0.00% -18.40% -39.22% 0.60% -11.03% 92.16% -1.49% -29.88% 69.55% 34.85% 11.98%
EBIT Q/Q Growth
0.00% -24.70% -55.99% -0.81% -23.79% 207.80% -2.20% -43.58% 121.16% 47.02% 14.49%
NOPAT Q/Q Growth
0.00% -23.71% -56.71% 12.46% -31.66% 204.82% -3.67% -38.42% 107.93% 45.89% 14.67%
Net Income Q/Q Growth
0.00% -25.74% -57.48% 13.95% -34.51% 212.39% -3.26% -38.07% 105.67% 47.13% 15.08%
EPS Q/Q Growth
0.00% -22.54% -60.82% 20.95% -47.24% 288.06% 1.15% -38.40% 99.38% 56.04% 15.08%
Operating Cash Flow Q/Q Growth
-69.77% 223.13% -12.43% -43.62% -50.37% 101.10% 82.92% -40.33% 10.89% 58.01% 59.71%
Free Cash Flow Firm Q/Q Growth
0.00% -16,803.54% 91.68% -9.63% 19.11% -17.10% 11.89% -10.50% 27.31% 63.71% 93.28%
Invested Capital Q/Q Growth
0.00% 0.84% 1.75% 2.50% 2.91% 3.83% 0.58% 1.95% 2.43% 1.77% -0.47%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
18.72% 14.78% 10.18% 8.86% 7.73% 14.46% 13.94% 11.21% 15.81% 19.56% 20.68%
EBITDA Margin
18.35% 15.09% 9.95% 10.53% 8.47% 15.07% 14.73% 11.45% 15.71% 19.35% 20.03%
Operating Margin
14.47% 10.98% 5.24% 5.47% 3.77% 10.74% 10.42% 6.52% 11.67% 15.67% 16.58%
EBIT Margin
14.47% 10.98% 5.24% 5.47% 3.77% 10.74% 10.42% 6.52% 11.67% 15.67% 16.58%
Profit (Net Income) Margin
11.79% 8.82% 4.07% 4.88% 2.89% 8.35% 8.02% 5.50% 9.16% 12.31% 13.09%
Tax Burden Percent
78.26% 79.29% 77.99% 88.43% 79.30% 78.53% 77.35% 84.43% 79.38% 78.77% 78.90%
Interest Burden Percent
104.04% 101.28% 99.49% 100.80% 96.61% 99.01% 99.44% 100.00% 98.92% 99.75% 100.11%
Effective Tax Rate
21.74% 20.71% 22.01% 11.57% 20.70% 21.47% 22.65% 15.57% 20.62% 21.23% 21.10%
Return on Invested Capital (ROIC)
17.18% 24.50% 5.69% 6.46% 3.79% 10.58% 10.35% 7.04% 12.14% 16.64% 18.96%
ROIC Less NNEP Spread (ROIC-NNEP)
19.39% 25.74% 5.53% 6.68% 3.48% 10.34% 10.22% 7.04% 11.91% 16.56% 19.00%
Return on Net Nonoperating Assets (RNNOA)
1.57% 1.72% 0.26% 0.39% 0.42% 1.40% 1.45% 1.17% 2.31% 3.26% 3.12%
Return on Equity (ROE)
18.75% 26.23% 5.95% 6.84% 4.21% 11.98% 11.80% 8.21% 14.45% 19.89% 22.08%
Cash Return on Invested Capital (CROIC)
15.57% -168.34% 2.62% -0.55% -1.30% -4.34% -1.71% -1.03% 1.71% 5.56% 9.53%
Operating Return on Assets (OROA)
14.93% 10.50% 4.79% 4.85% 3.34% 9.67% 9.61% 6.13% 11.33% 15.90% 17.60%
Return on Assets (ROA)
12.16% 8.43% 3.72% 4.33% 2.56% 7.52% 7.39% 5.18% 8.90% 12.49% 13.90%
Return on Common Equity (ROCE)
17.87% 24.96% 5.65% 6.48% 4.00% 11.38% 11.19% 7.78% 13.74% 18.89% 20.91%
Return on Equity Simple (ROE_SIMPLE)
22.42% 18.17% 13.91% 0.00% 7.90% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
922 703 304 342 234 713 687 423 880 1,283 1,471
NOPAT Margin
11.33% 8.71% 4.09% 4.84% 2.99% 8.43% 8.06% 5.50% 9.26% 12.34% 13.08%
Net Nonoperating Expense Percent (NNEP)
-2.21% -1.23% 0.15% -0.22% 0.31% 0.24% 0.13% 0.00% 0.23% 0.07% -0.04%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.21% 0.81% 2.51% 2.39% 1.45% 2.96% 4.23% 4.72%
Cost of Revenue to Revenue
81.28% 85.22% 89.82% 91.14% 92.27% 85.54% 86.06% 88.79% 84.19% 80.44% 79.32%
SG&A Expenses to Revenue
4.24% 3.80% 3.29% 3.19% 3.59% 3.60% 3.52% 4.35% 3.98% 3.90% 3.95%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
4.24% 3.80% 4.94% 3.39% 3.96% 3.73% 3.52% 4.70% 4.14% 3.90% 4.10%
Earnings before Interest and Taxes (EBIT)
1,178 887 390 387 295 908 888 501 1,108 1,629 1,865
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,493 1,219 741 745 663 1,274 1,255 880 1,492 2,012 2,253
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.35 1.83 1.74 1.35 1.19 1.56 1.53 1.78 1.83 2.27 2.39
Price to Tangible Book Value (P/TBV)
3.55 2.77 2.74 2.13 1.87 2.43 2.34 2.71 2.74 3.34 3.45
Price to Revenue (P/Rev)
1.43 1.16 1.14 0.89 0.78 1.03 0.99 1.15 1.15 1.39 1.40
Price to Earnings (P/E)
11.49 11.09 14.11 13.52 17.78 24.55 19.17 21.40 16.85 17.43 15.17
Dividend Yield
1.06% 1.35% 1.44% 1.86% 2.11% 1.59% 1.59% 1.35% 1.29% 1.01% 0.93%
Earnings Yield
8.70% 9.02% 7.09% 7.40% 5.62% 4.07% 5.22% 4.67% 5.93% 5.74% 6.59%
Enterprise Value to Invested Capital (EV/IC)
2.21 1.74 1.64 1.29 1.15 1.44 1.42 1.62 1.66 2.02 2.15
Enterprise Value to Revenue (EV/Rev)
1.49 1.24 1.24 1.02 0.94 1.21 1.16 1.32 1.32 1.55 1.53
Enterprise Value to EBITDA (EV/EBITDA)
7.28 6.86 8.08 7.47 8.51 10.90 9.39 10.55 9.19 9.90 8.93
Enterprise Value to EBIT (EV/EBIT)
8.79 8.71 11.10 11.03 14.63 18.84 14.91 16.57 13.22 13.53 11.62
Enterprise Value to NOPAT (EV/NOPAT)
11.18 10.99 14.00 13.80 18.10 23.40 18.69 20.87 16.66 17.06 14.61
Enterprise Value to Operating Cash Flow (EV/OCF)
8.01 6.82 8.14 7.88 7.38 11.92 11.66 13.28 11.99 12.62 11.14
Enterprise Value to Free Cash Flow (EV/FCFF)
14.55 0.00 65.55 0.00 0.00 0.00 0.00 0.00 101.02 37.48 23.22
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.32 0.32 0.32 0.32 0.37 0.32 0.31 0.32 0.32 0.31 0.29
Long-Term Debt to Equity
0.31 0.26 0.26 0.27 0.32 0.31 0.30 0.31 0.31 0.27 0.27
Financial Leverage
0.08 0.07 0.05 0.06 0.12 0.14 0.14 0.17 0.19 0.20 0.16
Leverage Ratio
1.59 1.57 1.59 1.59 1.60 1.58 1.59 1.59 1.61 1.59 1.59
Compound Leverage Factor
1.65 1.59 1.59 1.60 1.55 1.57 1.58 1.59 1.59 1.59 1.59
Debt to Total Capital
23.98% 24.04% 24.35% 24.50% 27.18% 24.25% 23.81% 24.35% 24.01% 23.38% 22.75%
Short-Term Debt to Total Capital
0.71% 4.34% 4.40% 4.47% 4.11% 0.67% 0.58% 0.72% 0.83% 2.34% 2.27%
Long-Term Debt to Total Capital
23.26% 19.71% 19.95% 20.03% 23.07% 23.59% 23.23% 23.62% 23.18% 21.04% 20.47%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.61% 3.66% 3.80% 3.96% 3.61% 3.89% 4.03% 4.06% 3.69% 3.81% 4.10%
Common Equity to Total Capital
72.41% 72.30% 71.85% 71.54% 69.22% 71.86% 72.16% 71.59% 72.30% 72.81% 73.15%
Debt to EBITDA
0.98 1.17 1.44 1.66 2.34 2.01 1.74 1.75 1.45 1.26 1.07
Net Debt to EBITDA
0.19 0.25 0.43 0.67 1.13 1.28 1.04 1.09 0.95 0.78 0.52
Long-Term Debt to EBITDA
0.95 0.96 1.18 1.35 1.99 1.96 1.70 1.70 1.40 1.13 0.96
Debt to NOPAT
1.50 1.87 2.50 3.06 4.98 4.32 3.47 3.46 2.64 2.17 1.75
Net Debt to NOPAT
0.29 0.40 0.75 1.24 2.41 2.76 2.08 2.15 1.72 1.35 0.85
Long-Term Debt to NOPAT
1.46 1.54 2.05 2.50 4.22 4.20 3.38 3.36 2.54 1.95 1.57
Altman Z-Score
5.12 4.43 4.14 3.77 3.44 4.01 4.00 4.22 4.39 4.84 4.98
Noncontrolling Interest Sharing Ratio
4.67% 4.82% 4.94% 5.30% 4.85% 4.97% 5.16% 5.31% 4.90% 5.05% 5.30%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.02 2.93 2.59 2.51 2.52 2.83 2.77 2.94 2.90 2.51 2.46
Quick Ratio
2.39 1.76 1.50 1.37 1.39 1.42 1.42 1.45 1.45 1.28 1.36
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-133 -22,527 -1,874 -2,055 -1,662 -1,946 -1,715 -1,895 -1,377 -500 -34
Operating Cash Flow to CapEx
69.03% 186.64% 158.56% 83.91% 42.52% 79.74% 166.54% 100.00% 136.94% 248.23% 362.99%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -257.37 -730.94 -118.72 -102.44 -114.33 -172.27 -72.50 -41.65 -4.80
Operating Cash Flow to Interest Expense
0.00 0.00 178.62 260.89 26.00 38.53 89.27 72.64 46.63 116.67 319.43
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 65.97 -50.02 -35.14 -9.79 35.67 0.00 12.58 69.67 231.43
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.03 0.96 0.91 0.89 0.89 0.90 0.92 0.94 0.97 1.01 1.06
Accounts Receivable Turnover
10.01 10.50 9.84 10.92 9.94 9.48 10.22 11.24 10.46 9.71 10.24
Inventory Turnover
4.79 5.07 5.11 4.99 5.02 5.15 5.37 5.42 5.39 5.32 5.63
Fixed Asset Turnover
3.20 2.72 2.73 2.53 2.41 2.34 2.33 2.28 2.33 2.39 2.51
Accounts Payable Turnover
14.77 15.28 14.10 13.83 14.01 14.05 13.95 15.38 13.42 13.44 14.19
Days Sales Outstanding (DSO)
36.45 34.75 37.11 33.42 36.72 38.51 35.70 32.46 34.90 37.58 35.65
Days Inventory Outstanding (DIO)
76.13 71.95 71.45 73.21 72.65 70.89 67.98 67.40 67.69 68.67 64.87
Days Payable Outstanding (DPO)
24.71 23.88 25.88 26.40 26.05 25.98 26.16 23.74 27.21 27.15 25.72
Cash Conversion Cycle (CCC)
87.88 82.82 82.67 80.24 83.33 83.42 77.52 76.12 75.38 79.09 74.80
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
23,038 23,231 23,637 24,228 24,934 25,890 26,039 26,546 27,191 27,673 27,544
Invested Capital Turnover
1.52 2.81 1.39 1.33 1.27 1.25 1.28 1.28 1.31 1.35 1.45
Increase / (Decrease) in Invested Capital
1,055 23,231 2,179 2,397 1,896 2,659 2,402 2,318 2,257 1,783 1,505
Enterprise Value (EV)
50,996 40,409 38,796 31,339 28,661 37,315 36,954 42,939 45,020 55,838 59,272
Market Capitalization
48,652 37,902 35,632 27,405 23,796 31,814 31,685 37,329 39,282 50,274 54,539
Book Value per Share
$85.13 $86.43 $86.26 $86.43 $87.05 $88.36 $90.49 $91.48 $94.19 $97.08 $100.54
Tangible Book Value per Share
$56.31 $57.02 $54.80 $54.82 $55.15 $56.70 $58.96 $60.12 $62.96 $66.15 $69.77
Total Capital
28,577 28,665 28,496 28,367 28,995 28,373 28,784 29,245 29,672 30,365 31,184
Total Debt
6,851 6,892 6,939 6,950 7,880 6,881 6,853 7,121 7,124 7,099 7,093
Total Long-Term Debt
6,648 5,649 5,685 5,683 6,689 6,692 6,686 6,909 6,877 6,389 6,384
Net Debt
1,312 1,458 2,081 2,811 3,819 4,398 4,108 4,422 4,643 4,407 3,453
Capital Expenditures (CapEx)
666 796 820 874 856 918 804 799 647 564 616
Debt-free, Cash-free Net Working Capital (DFCFNWC)
5,662 5,202 4,700 4,626 4,831 5,279 4,973 5,274 5,687 5,928 5,593
Debt-free Net Working Capital (DFNWC)
11,201 10,637 9,559 8,765 8,892 7,762 7,718 7,973 8,168 8,620 9,233
Net Working Capital (NWC)
10,997 9,393 8,304 7,498 7,701 7,573 7,551 7,761 7,921 7,910 8,524
Net Nonoperating Expense (NNE)
-37 -8.99 1.56 -2.75 7.93 7.07 3.87 0.00 9.53 3.15 -1.58
Net Nonoperating Obligations (NNO)
1,312 1,458 2,081 2,811 3,819 4,398 4,108 4,422 4,643 4,407 3,453
Total Depreciation and Amortization (D&A)
316 332 350 358 368 366 367 379 384 383 388
Debt-free, Cash-free Net Working Capital to Revenue
16.58% 15.91% 14.99% 15.05% 15.88% 17.14% 15.60% 16.23% 16.65% 16.42% 14.40%
Debt-free Net Working Capital to Revenue
32.81% 32.53% 30.48% 28.52% 29.22% 25.20% 24.21% 24.54% 23.91% 23.88% 23.78%
Net Working Capital to Revenue
32.21% 28.73% 26.48% 24.40% 25.31% 24.58% 23.68% 23.88% 23.19% 21.91% 21.95%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.46 $2.68 $1.05 $1.28 $0.67 $2.60 $2.63 $1.63 $3.23 $5.05 $5.81
Adjusted Weighted Average Basic Shares Outstanding
243.10M 239.58M 236.46M 230.54M 232.70M 230.60M 229.90M 227.77M 228.90M 228.20M 226.40M
Adjusted Diluted Earnings per Share
$3.46 $2.68 $1.05 $1.27 $0.67 $2.60 $2.63 $1.62 $3.23 $5.04 $5.80
Adjusted Weighted Average Diluted Shares Outstanding
243.50M 239.94M 236.77M 230.54M 232.90M 230.80M 230.20M 227.77M 229.30M 228.50M 226.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
239.76M 237.34M 234.81M 230.54M 230.75M 229.54M 228.86M 227.77M 227.74M 226.88M 224.94M
Normalized Net Operating Profit after Tax (NOPAT)
922 703 400 342 257 722 687 446 891 1,283 1,485
Normalized NOPAT Margin
11.33% 8.71% 5.38% 4.84% 3.28% 8.53% 8.06% 5.80% 9.39% 12.34% 13.20%
Pre Tax Income Margin
15.06% 11.12% 5.22% 5.52% 3.64% 10.63% 10.36% 6.52% 11.54% 15.63% 16.60%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 53.59 137.71 21.07 47.79 59.20 45.55 58.32 135.75 266.43
NOPAT to Interest Expense
0.00 0.00 41.80 121.78 16.71 37.53 45.79 38.45 46.29 106.93 210.20
EBIT Less CapEx to Interest Expense
0.00 0.00 -59.06 -173.20 -40.07 -0.53 5.60 -27.09 24.26 88.75 178.43
NOPAT Less CapEx to Interest Expense
0.00 0.00 -70.85 -189.13 -44.43 -10.79 -7.81 -34.18 12.24 59.93 122.20
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
18.97% 23.38% 30.79% 37.69% 48.93% 48.54% 38.93% 37.34% 30.16% 25.46% 20.88%
Augmented Payout Ratio
64.86% 81.24% 103.81% 133.29% 145.08% 126.08% 86.12% 72.13% 49.74% 46.19% 47.50%

Financials Breakdown Chart

Key Financial Trends

Nucor’s Q2 2026 results show a significant rebound in profitability and cash generation. Revenue increased to $10.4 billion from $9.5 billion in Q1 2026 and $8.5 billion in Q2 2025. Gross profit rose to $2.0 billion, producing a gross margin of approximately 19.6%, up from 15.8% in Q1 and 14.5% in the year-ago quarter. Operating income increased to $1.6 billion, while net income attributable to common shareholders reached $1.16 billion, or $5.04 per diluted share.

The improvement follows a sharp earnings decline from the exceptionally strong 2022 and early 2023 periods. Quarterly revenue has generally remained below the $10.5 billion recorded in Q3 2022, while gross profit and EPS also remain below those peak levels. However, the Q2 2026 recovery is notable: diluted EPS increased from $1.27 in Q4 2024 and $1.62 in Q4 2025 to $5.04 in the latest quarter. Selling, general and administrative expense remains well controlled relative to revenue, and Q2 2026 included no impairment charge.

Cash flow and liquidity were solid in Q2 2026. Operating cash flow was $1.4 billion, more than enough to fund $571 million of capital expenditures, $350 million of share repurchases and $191 million of dividends. Cash and short-term investments totaled approximately $2.7 billion at quarter-end, while total debt was about $7.1 billion. The balance sheet remains well capitalized, although working capital requirements and ongoing investment spending warrant monitoring.

  • Strong sequential and year-over-year earnings recovery: Q2 2026 revenue rose 9.9% from Q1 and 22.9% from Q2 2025, while diluted EPS increased to $5.04 from $3.23 and $2.60, respectively.
  • Improved margins: Gross margin expanded to approximately 19.6% from 15.8% in Q1 2026 and 14.5% in Q2 2025, indicating better profitability after cost of revenue.
  • Operating cash flow strengthened: Cash flow from operations increased to $1.4 billion in Q2 from $886 million in Q1 and $732 million in Q2 2025.
  • Capital returns remain substantial: Nucor returned approximately $541 million to shareholders through $350 million of repurchases and $191 million of dividends during Q2 2026.
  • Capital spending is supported by internal cash generation: Q2 capital expenditures of $571 million were comfortably covered by operating cash flow, leaving positive quarterly free cash flow before financing distributions.
  • Liquidity improved during the quarter: Cash and equivalents increased to $2.48 billion from $2.23 billion in Q1, while total current assets rose to $13.2 billion.
  • Share count continues to decline gradually: Diluted weighted-average shares fell to 228.5 million in Q2 2026 from 230.8 million in Q2 2025, supporting per-share results, although the reduction was modest compared with the size of the earnings improvement.
  • Balance-sheet equity continued to build: Total equity and noncontrolling interests increased to $23.3 billion from $21.5 billion in Q2 2025, supported by higher retained earnings.
  • Working capital absorbed cash: Changes in operating assets and liabilities reduced Q2 operating cash flow by $317 million. Accounts receivable increased to $4.0 billion and inventories rose to $6.0 billion from Q2 2025 levels.
  • Debt remains material and investment spending is high: Total debt was approximately $7.1 billion at quarter-end, while Q2 capital expenditures and the first-half total of roughly $1.2 billion could pressure free cash flow if profitability weakens.
11/14/26 08:02 PM ETAI Generated. May Contain Errors.

Nucor Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nucor's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Nucor's net income appears to be on an upward trend, with a most recent value of $2.04 billion in 2025, rising from $193.03 million in 2015. The previous period was $2.32 billion in 2024. Find out what analysts predict for Nucor in the coming months.

Nucor's total operating income in 2025 was $2.59 billion, based on the following breakdown:
  • Total Gross Profit: $3.88 billion
  • Total Operating Expenses: $1.29 billion

Over the last 10 years, Nucor's total revenue changed from $16.44 billion in 2015 to $32.49 billion in 2025, a change of 97.7%.

In the past 11 quarters, Nucor's cash and equivalents has ranged from $1.95 billion in Q2 2025 to $6.38 billion in Q4 2023, and is currently $3.47 billion as of their latest financial filing in Q3 2026.

Nucor had total debt of $7.12 billion at the end of 2025, a 2.5% increase from 2024, and a 62.3% increase since 2015.

Over the last 10 years, Nucor's book value per share changed from 23.40 in 2015 to 91.48 in 2025, a change of 291.0%.



Financial statements for NYSE:NUE last updated on 11/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners